K-numberK250421
Device nameInThrill™ Thrombectomy System
ApplicantInari Medical, Inc.
Product codeQEW
Device classClass II
Decision dateMay 12, 2025
DecisionSubstantially Equivalent
Regulation870.5150
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The InThrill™ Thrombectomy System is a minimally invasive catheter-based device designed to remove blood clots (emboli and thrombi) from peripheral blood vessels, including dialysis access grafts and synthetic grafts. It comprises an 8 Fr sheath and an 8 Fr catheter that work together to capture and extract clots, and can also be used for injection or aspiration of contrast media and other fluids.

Technological characteristics

The subject device differs from the predicate in: a longer sheath tip taper; changes to the coring element (longer length, smaller diameter, different geometry); decreased Pebax durometer at the sheath shaft tip and increased durometer at the catheter shaft tip; a change from two coaxial braided shafts to a single, thicker shaft; and the addition of an element support tool accessory. Shelf-life is 6 months versus 2 years for the predicate. Product codes expand from QEW, KRA to QEW, KRA, DYB.

Test standards cited

ISO 10993-1 (biocompatibility), ISO 11135:2014/Amd 1:2018 (sterilization by ethylene oxide), and AAMI TIR 28:2016 (sterilization standards). Testing included biocompatibility assays (cytotoxicity, sensitization, thromboresistance), performance verification (dimensional, hemostasis, tensile, torque, corrosion), and system validation (clot removal efficacy, deployment, leak testing).

Substantial equivalence argument

The device has identical intended use and principles of operation as the predicate (same indications, peripheral vasculature use, same guidewire compatibility). Although dimensional and material modifications were made, comprehensive non-clinical performance testing demonstrated all acceptance criteria were met and that these design changes do not raise new or different safety or effectiveness concerns. The biocompatibility and sterilization processes meet established standards, and the device maintains functional equivalence for clot removal despite the engineering refinements.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →